Members of the Alliance for Genomic Discovery revealed
Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members
Read Moreby John Pinching | Jul 19, 2023 | News | 0
Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members
Read Moreby Selina McKee | May 13, 2020 | News | 0
Thousands of patients severely ill with coronavirus are to have their genetic code studied to help uncover whether genetics play a role in susceptibility to the virus.
Read Moreby Anna Smith | Jan 14, 2020 | News | 0
The partnership comes off the back of the success of the 100,000 Genomes Project in December 2018.
Read Moreby Selina McKee | Jul 4, 2018 | News | 0
Genomics England says the 100,000 Genomes Project is “well on track” to reach its target of sequencing 100,000 genomes by the end of this year.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
